Strides Pharma Science gets USFDA nod for generic capsule to control triglyceride level

Strides Pharma Science Ltd on Tuesday said its wholly-owned arm has received approval from the US health regulator for its generic version of Icosapent Ethyl capsules used to control triglyceride levels in the blood. The approval granted by the US Food & Drug Administration (USFDA) to Strides Pharma Global Pte. Limited, Singapore, is for Icosapent Ethyl Capsules 0.5 gram and 1 gram, Strides Pharma Science said in a regulatory filing.

The product is bioequivalent and therapeutically equivalent to the reference listed drug Vascepa of Amarin.

Read more

    To Top

    As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Abacus Legal Group (ALG) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ALG or any of its members to solicit any work through this website.